Senti Biosciences (SNTI) Competitors $3.00 -0.21 (-6.54%) Closing price 04:00 PM EasternExtended Trading$3.16 +0.16 (+5.17%) As of 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNTI vs. ANRO, SKYE, IGMS, ALGS, ADAP, ENTX, IMAB, EPIX, ALTS, and ZIVOShould you be buying Senti Biosciences stock or one of its competitors? The main competitors of Senti Biosciences include Alto Neuroscience (ANRO), Skye Bioscience (SKYE), IGM Biosciences (IGMS), Aligos Therapeutics (ALGS), Adaptimmune Therapeutics (ADAP), Entera Bio (ENTX), I-Mab (IMAB), ESSA Pharma (EPIX), Janone (ALTS), and ZIVO Bioscience (ZIVO). These companies are all part of the "pharmaceutical products" industry. Senti Biosciences vs. Alto Neuroscience Skye Bioscience IGM Biosciences Aligos Therapeutics Adaptimmune Therapeutics Entera Bio I-Mab ESSA Pharma Janone ZIVO Bioscience Senti Biosciences (NASDAQ:SNTI) and Alto Neuroscience (NYSE:ANRO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, community ranking, media sentiment, valuation and risk. Which has more volatility and risk, SNTI or ANRO? Senti Biosciences has a beta of 2.52, suggesting that its share price is 152% more volatile than the S&P 500. Comparatively, Alto Neuroscience has a beta of 2.14, suggesting that its share price is 114% more volatile than the S&P 500. Does the media favor SNTI or ANRO? In the previous week, Senti Biosciences had 1 more articles in the media than Alto Neuroscience. MarketBeat recorded 1 mentions for Senti Biosciences and 0 mentions for Alto Neuroscience. Senti Biosciences' average media sentiment score of 1.00 beat Alto Neuroscience's score of 0.00 indicating that Senti Biosciences is being referred to more favorably in the media. Company Overall Sentiment Senti Biosciences Positive Alto Neuroscience Neutral Is SNTI or ANRO more profitable? Alto Neuroscience's return on equity of -49.28% beat Senti Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Senti BiosciencesN/A -154.84% -77.42% Alto Neuroscience N/A -49.28%-33.52% Does the MarketBeat Community favor SNTI or ANRO? Alto Neuroscience received 11 more outperform votes than Senti Biosciences when rated by MarketBeat users. Likewise, 83.33% of users gave Alto Neuroscience an outperform vote while only 40.00% of users gave Senti Biosciences an outperform vote. CompanyUnderperformOutperformSenti BiosciencesOutperform Votes440.00% Underperform Votes660.00% Alto NeuroscienceOutperform Votes1583.33% Underperform Votes316.67% Do insiders & institutionals have more ownership in SNTI or ANRO? 25.7% of Senti Biosciences shares are owned by institutional investors. 10.7% of Senti Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has higher valuation & earnings, SNTI or ANRO? Alto Neuroscience has lower revenue, but higher earnings than Senti Biosciences. Alto Neuroscience is trading at a lower price-to-earnings ratio than Senti Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSenti Biosciences$2.56M31.18-$71.06M-$12.03-0.26Alto NeuroscienceN/AN/A-$36.31M-$2.54-0.73 Do analysts prefer SNTI or ANRO? Senti Biosciences presently has a consensus price target of $10.00, suggesting a potential upside of 225.73%. Alto Neuroscience has a consensus price target of $16.75, suggesting a potential upside of 800.54%. Given Alto Neuroscience's higher probable upside, analysts plainly believe Alto Neuroscience is more favorable than Senti Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Senti Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Alto Neuroscience 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummarySenti Biosciences and Alto Neuroscience tied by winning 8 of the 16 factors compared between the two stocks. Remove Ads Get Senti Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SNTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNTI vs. The Competition Export to ExcelMetricSenti BiosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$79.83M$2.96B$5.58B$7.57BDividend YieldN/A1.53%5.35%4.04%P/E Ratio-0.2030.5822.9818.19Price / Sales31.18388.15362.8486.44Price / CashN/A168.6838.1634.64Price / Book0.203.636.534.03Net Income-$71.06M-$72.06M$3.21B$247.18M7 Day Performance-7.81%-9.84%-5.84%-5.61%1 Month Performance7.34%-16.02%-0.12%-6.72%1 Year Performance-10.00%-30.11%6.42%-3.53% Senti Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNTISenti Biosciences2.8701 of 5 stars$3.00-6.5%$10.00+233.3%-8.0%$78.01M$2.56M-0.194Gap UpANROAlto Neuroscience1.0498 of 5 stars$2.65-0.2%$16.75+533.3%-85.4%$71.34MN/A-1.04N/AGap DownSKYESkye Bioscience1.1836 of 5 stars$2.35+4.4%$18.00+666.0%-89.9%$71.29MN/A-3.2611Gap DownIGMSIGM Biosciences4.7258 of 5 stars$1.26+5.9%$5.50+336.5%-86.5%$71.13M$2.68M-0.35190Short Interest ↓Gap DownALGSAligos Therapeutics3.8878 of 5 stars$11.63+8.2%$70.00+501.9%-69.0%$71.11M$3.95M-0.8790Analyst ForecastGap DownADAPAdaptimmune Therapeutics2.6354 of 5 stars$0.28-4.8%$2.18+687.6%-78.2%$70.83M$175.04M-1.26490Analyst ForecastGap DownENTXEntera Bio2.5663 of 5 stars$1.95flat$10.00+412.8%-9.7%$69.78M$99,000.00-7.5020Earnings ReportShort Interest ↓Gap DownIMABI-Mab1.962 of 5 stars$0.87+2.0%$7.00+706.6%-57.2%$69.33M$3.27M0.00380News CoverageGap DownEPIXESSA Pharma2.808 of 5 stars$1.56-1.3%$9.50+509.0%-80.7%$69.25MN/A-2.2650ALTSJanoneN/A$4.91+3.8%N/AN/A$69.08M$7.11M0.00170Short Interest ↓News CoverageGap DownZIVOZIVO BioscienceN/A$18.00+1.1%N/A+110.0%$67.30M$15,850.00-3.6910Gap Down Remove Ads Related Companies and Tools Related Companies Alto Neuroscience Alternatives Skye Bioscience Alternatives IGM Biosciences Alternatives Aligos Therapeutics Alternatives Adaptimmune Therapeutics Alternatives Entera Bio Alternatives I-Mab Alternatives ESSA Pharma Alternatives Janone Alternatives ZIVO Bioscience Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNTI) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredWhy Elon Musk Is Investigating Fort KnoxWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senti Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNTI Stock Free SNTI Stock Alerts